Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meng-Di Ma

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
American Journal of Translational Research|June 12, 2023
Prognostic model for the prediction of cancer-specific survival in elderly patients with stage I-III gastric cancerKe-Xun Yu, Jing Li, Hui-Zhen Wang, et al.
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
Bromodomain and Extra-Terminal Inhibitor BMS-986158 Reverses Latent HIV-1 Infection In Vitro and Ex Vivo by Increasing CDK9 Phosphorylation and RecruitmentXu-Sheng Huang, Ren-Rong Tian, Meng-Di Ma, et al.
Viruses|January 28, 2026
Anti-HIV-1 Activity of the Integrase Strand Transfer Inhibitor ACC017Meng-Di Ma, Rong-Hua Luo, Chun-Yan Li, et al.
ACS Medicinal Chemistry Letters|January 17, 2024
Novel Triazolopyridine-Based BRD4 Inhibitors as Potent HIV-1 Latency Reversing AgentsYan-Kai Wang, Xu-Sheng Huang, Hao Sun, et al.
Drug Development Research|February 8, 2023
Synthesis and anti-HIV activity of non-nucleoside reverse-transcriptase inhibitor DB02 phosphate derivatives based on water-soluble optimizationJing-Bo Wang, Meng-Di Ma, Nan Lu, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2025
Discovery of DC20 as a potential non-nucleoside reverse transcriptase inhibitor with excellent pharmacokinetic propertiesJia-Yu Liu, Meng-Di Ma, Yi-Ming Li, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
American Journal of Translational Research|June 12, 2023
Prognostic model for the prediction of cancer-specific survival in elderly patients with stage I-III gastric cancerKe-Xun Yu, Jing Li, Hui-Zhen Wang, et al.
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
Bromodomain and Extra-Terminal Inhibitor BMS-986158 Reverses Latent HIV-1 Infection In Vitro and Ex Vivo by Increasing CDK9 Phosphorylation and RecruitmentXu-Sheng Huang, Ren-Rong Tian, Meng-Di Ma, et al.
Viruses|January 28, 2026
Anti-HIV-1 Activity of the Integrase Strand Transfer Inhibitor ACC017Meng-Di Ma, Rong-Hua Luo, Chun-Yan Li, et al.
ACS Medicinal Chemistry Letters|January 17, 2024
Novel Triazolopyridine-Based BRD4 Inhibitors as Potent HIV-1 Latency Reversing AgentsYan-Kai Wang, Xu-Sheng Huang, Hao Sun, et al.
Drug Development Research|February 8, 2023
Synthesis and anti-HIV activity of non-nucleoside reverse-transcriptase inhibitor DB02 phosphate derivatives based on water-soluble optimizationJing-Bo Wang, Meng-Di Ma, Nan Lu, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2025
Discovery of DC20 as a potential non-nucleoside reverse transcriptase inhibitor with excellent pharmacokinetic propertiesJia-Yu Liu, Meng-Di Ma, Yi-Ming Li, et al.
Pageof 1